Antidepressants linked to cataract risk -- Parkinson's drug may cause corneal damage

This month's Ophthalmology, the journal of the American Academy of Ophthalmology, includes new studies on links between eye diseases and two widely-prescribed drugs: SSRI (selective serotonin reuptake inhibitor) antidepressants, and amantadine, a Parkinson's disease treatment.

Read the whole article on Physorg

More from Physorg